
Quinazoline and Quinoline Derivatives
Quinazolines and quinolines are nitrogen-containing heterocyclic compounds with aromatic structures that play a key role in the synthesis of drugs with anticancer, antimicrobial, and anti-inflammatory activity. Their derivatives feature structural modifications that optimise bioavailability and selectivity, enabling the development of new active ingredients for various therapeutic applications. These compounds are used in the manufacture of APIs for the treatment of cancer, infections, neurodegenerative diseases, and cardiovascular conditions. Additionally, quinazoline and quinoline derivatives are essential in the research of enzyme inhibitors and the design of innovative bioactive molecules.
At CymitQuimica, we offer high-purity quinazoline and quinoline derivatives for applications in chemical synthesis, pharmaceutical development, and biotechnology.
Found 65630 products of "Quinazoline and Quinoline Derivatives"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Racecadotril
CAS:Controlled Product<p>Applications Antidiarrheal; enkephalinase inhibitor, reducing the amount of water and electrolytes into the intestine.<br>References Cezard, J., et al.: Gastroenterol., 120, 799 (2001), Sato, T., et al.: J. Med. Chem., 51, 7705 (2008), Lakshmana, P., et al.: J. Pharm. Res., 8, 39 (2009),<br></p>Formula:C21H23NO4SColor and Shape:NeatMolecular weight:385.481,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic Acid 3-Methyl Ester
CAS:<p>Impurity Nicardipine USP Related Compound A<br>Applications 1,4-Dihydropyridine derivative used in the prevention and therapy of atherosclerotic degradation of arterial walls. Nicardipine USP Related Compound A.<br>References Henry, P.D., et al.: Clin. Invest. Med., 10, 601 (1987), Weinstein, D.B., et al.: Am. J. Med., 86, 27 (1989), Gaviraghi, G., et al.: Pharmacol. Res., 31, 251 (1995),<br></p>Formula:C16H16N2O6Color and Shape:Light YellowMolecular weight:332.312-[3-(4-nitrophenyl)-1-phenyl-1h-pyrazol-4-yl]acetic acid
CAS:Purity:97%Molecular weight:323.30801391601562-(4-Methoxyphenyl)-1-oxo-1,2-dihydroisoquinoline-4-carboxylic acid
CAS:Purity:97%Molecular weight:295.294006347656253’-Acetyl-4’-(2,3-epoxypropoxy)butyranilide
CAS:<p>Impurity Acebutolol EP Impurity A<br>Applications 3’-Acetyl-4’-(2,3-epoxypropoxy)butyranilide (Acebutolol EP Impurity A) is a useful intermediate in the preparation of Acebutolol.<br>References Andresen, B., et al.: Drug Metab. Disposition, 7, 360 (1979),<br></p>Formula:C15H19NO4Color and Shape:Off-WhiteMolecular weight:277.321-(4-Chlorophenyl)-5-(furan-2-yl)-1h-pyrazole-3-carboxylic acid
CAS:Purity:95%Molecular weight:288.690002441406257-Methoxy-1-naphthaleneethanamine Hydrochloride
CAS:Controlled ProductFormula:C13H15NO·ClHColor and Shape:NeatMolecular weight:237.73Riluzole-13C,15N2
CAS:Controlled ProductFormula:C713CH5F315N2OSColor and Shape:Light Beige To Light YellowMolecular weight:237.18Ethyl 2,4-dichloroquinazoline-6-carboxylate
CAS:Formula:C11H8Cl2N2O2Purity:95%Color and Shape:SolidMolecular weight:271.1Brexpiprazole S-Oxide
CAS:<p>Applications Brexpiprazole S-Oxide is an impurity and potential metabolite of Brexpiprazole (B677385), a drug candidate useful in treatment and prevention of mental disorders including CNS disorders.<br>References Yamashita, H., et al.: PCT Int. Appl., WO 2006112464 A1 20061026 (2006);<br></p>Formula:C25H27N3O3SColor and Shape:NeatMolecular weight:449.5653-piperazin-1-yl-6-(2-thienyl)pyridazine
CAS:Purity:95.0%Color and Shape:SolidMolecular weight:246.3300018310547ent-Ezetimibe
CAS:<p>Applications An enantiomeric impurity of Ezetimibe (E975005).<br></p>Formula:C24H21F2NO3Color and Shape:White To Off-WhiteMolecular weight:409.43Hydroxymethyl Ivacaftor
CAS:Controlled Product<p>Applications Hydroxymethyl Ivacaftor is an impurity of Ivacaftor (I940600); a drug used in the treatment of cystic fibrosis.<br>References Clancy, J. et al.: Am. J. Resp. Crit. Care. Med., 186, 593 (2012)<br></p>Formula:C24H28N2O4Color and Shape:NeatMolecular weight:408.49Chlorprothixene-d6 Hydrochloride
CAS:Controlled Product<p>Applications Labelled Chlorprothixene (C424850). Antipsychotic.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Rudy, B.C., et al.: Anal. Profiles Drug Subs., 2, 63 (1973), Bagli, M., et al.: Arzneim.-Forsch., 46, 247 (1996),<br></p>Formula:C18H13D6Cl2NSColor and Shape:White To Light YellowMolecular weight:358.36Medetomidine-13C,d3 Hydrochloride
CAS:Controlled Product<p>Applications Labelled α2-adrenergic agonist. Sedative; analgesic.<br>References Scheinin, M., et al.: Br. J. Clin. Pharmacol., 24, 443 (1987), Stenberg, D., et al.: J. Vet. Pharmacol. Ther., 10, 319 (1987), Virtanen, R., et al.: Eur. J. Pharmacol., 150, 9 (1988), Cullen, L.K., et al.: Br. Vet. J., 152, 519 (1996),<br></p>Formula:CC122H3H13N2·ClHColor and Shape:White To Light YellowMolecular weight:240.75(S,S)Dinitroso Ethambutol
CAS:Controlled ProductFormula:C10H22N4O4Color and Shape:WhiteMolecular weight:262.31Chlorpromazine-d6 Oxalate (N,N-dimethyl-d6)
CAS:Controlled Product<p>Applications Chlorpromazine-d6 Oxalate (N,N-dimethyl-d6) (CAS# 1276197-23-9) is a useful isotopically labeled research compound.<br></p>Formula:C17D6H13ClN2S·C2H2O4Color and Shape:Off-WhiteMolecular weight:414.93Sodium 4-butyl-3,5-dioxo-1,2-diphenylpyrazolidin-4-ide
CAS:Purity:97.0%Color and Shape:SolidMolecular weight:330.3630065917969Famotidine Acid Methyl Ester Hydrochloride (Famotidine Impurity)
CAS:Controlled Product<p>Applications Famotidine acid methyl ester hydrochloride salt is a Famotidine (F102250) impurity.<br>References Junnarkar, G., et al.: Pharm. Res., 12, 599 (1995), Singh, S., et al.: J. Pharm. Sci., 91, 253 (2002),<br></p>Formula:C9H14N4O2S2·ClHColor and Shape:NeatMolecular weight:310.821-[4-[(1,2,3,4-Tetrahydro-2-oxo-7-quinolinyl)oxy]butyl] Aripiprazole
CAS:<p>Impurity Aripiprazole Impurity 4<br>Applications 1-[4-[(1,2,3,4-Tetrahydro-2-oxo-7-quinolinyl)oxy]butyl] Aripiprazole is a synthetic impurity of the drug aripiprazole (A771000). Aripiprazole is a novel atypical antipsychotic drug used in the treatment of schizophrenia. Aripiprazole Impurity 4<br>References Filijovic, N. D., et al.: Acta Chromatogr., 26, 13 (2014)<br></p>Formula:C36H42Cl2N4O4Color and Shape:White To Off-WhiteMolecular weight:665.6491-(4-morpholinyl)cyclohexanecarboxylic acid hydrochloride hydrate
Purity:95.0%Molecular weight:267.75Captopril-d3
CAS:Controlled Product<p>Applications Orally active angiotensin-converting enzyme (ACE) inhibitor.<br>References Rubin, B., et al.: Eur. J Pharmacol., 51, 377 (1978),<br></p>Formula:C9D3H12NO3SColor and Shape:White SolidMolecular weight:220.304-Desmethyl-3-methyl Celecoxib
CAS:Controlled Product<p>Impurity Celecoxib Related Compound A<br>Applications 4-Desmethyl-3-methyl Celecoxib is a meta positional isomer of Celecoxib (C251000) with selective inhibitory activity against human cyclooxygenase-2. USP Celecoxib Related Compound A<br>References Sreenivas, R.D. et al.: J. Pharmac. Biomed. Anal., 25, 21 (2001);<br></p>Formula:C17H14F3N3O2SColor and Shape:White To Light YellowMolecular weight:381.37Sodium Borohydride
CAS:<p>Applications Sodium Borohydride is used as a reagent in the reduction of amino acids and their derivatives. Also used in the catalysis of ammonia borane dehydrogenation.<br> E0<br>References McKennon, M. et al.: J. Org. Chem., 58, 3568 (1993); Denney, M. et al.: J. Am. Chem. Soc., 128, 12048 (2006);<br></p>Formula:BH4NaColor and Shape:White To Off-WhiteMolecular weight:37.83N-Boc-Sitagliptin
CAS:Controlled Product<p>Applications N-Boc-Sitagliptin is the N-Boc protected derivative of Sitagliptin (S490990), a dipeptidyl peptidase-4 inhibitor that is used for glycemic control for patients with type 2 diabetes.<br>References Aschner, P., et al.: Diabetes Care, 29, 2632 (2006); Charbonnel, B., et al.: Diabetes Care, 29, 2638 (2006)<br></p>Formula:C21H23F6N5O3Color and Shape:NeatMolecular weight:507.435-Difluoromethoxy-2-[(3,4-dimethoxy-2-pyridinyl)methyl]thio-1H-benzimidazole
CAS:Purity:95.0%Molecular weight:367.3699951171875rac-Desmethyl Irinotecan Hydrochloride
CAS:Controlled Product<p>Impurity Irinotecan Related Compound C<br>Stability Hygroscopic<br>Applications Desmethyl Irinotecan Hydrochloride is an impurity in the synthesis of Irinotecan Hydrochloride (I767500), a DNA topoisomerase inhibitor.<br>References Kunimoto, T., et al.: Cancer Res., 47, 5944 (1987), Shimada, Y., et al.: J. Clin. Oncol., 11, 909 (1993);<br></p>Formula:C32H36N4O6·ClHColor and Shape:Light Yellow To YellowMolecular weight:609.114-phenyl-2-hydrophthalazin-1-one, 98%
CAS:Purity:95.0%Color and Shape:SolidMolecular weight:222.24699401855472,3-Di-furan-2-yl-quinoxaline-6-carboxylic acid
CAS:Color and Shape:SolidMolecular weight:306.2770080566406Ticagrelor Sulfoxide (Mixture of Diastereomers)
CAS:Controlled Product<p>Applications Ticagrelor Sulfoxide is an impurity of ticagrelor (T437700). Ticagrelor, the first reversible oral P2Y12 receptor antagonist, provides faster, greater, and more consistent ADP-receptor inhibition than Clopidogrel. Used in the treatment of acute coronary syndromes (ACS).<br>References Matetzky, S., et al.: Circulation, 109, 3171 (2004), Bassand, J., et al.: Eur. Heart J., 28, 1598 (2007), Jakubowski, J., et al.: Cardiovasc. Drug Rev., 25, 357 (2007),<br></p>Formula:C23H28F2N6O5SColor and Shape:NeatMolecular weight:538.577-chloro-8-methyl-2-pyridin-2-ylquinoline-4-carboxylic acid
CAS:Purity:95.0%Molecular weight:298.73001098632812-(4'-Chloro-[1,1'-biphenyl]-4-yl)-4,6-diphenyl-1,3,5-triazine
CAS:Purity:95%Molecular weight:419.91000366210942-Amino-4-(3-methoxy-phenyl)-thiophene-3-carboxylic acid methyl ester
CAS:Formula:C13H13NO3SPurity:98%Color and Shape:SolidMolecular weight:263.31(R)-Albuterol Hydrochloride
CAS:Controlled Product<p>Applications The R-enantiomer of Albuterol (A514500). A β2-adrenoceptor agonist. Bronchodilator; tocolytic.<br>References Han, et al.: Bioorg. Med. Chem., 14, 6043 (2006), Liyou, H., et al.: Biochem., 46, 1432 (2007), Agrawal, D., et al.: J. Allergy Clin. Immunol., 113, 503 (2004),<br></p>Formula:C13H21NO3·ClHColor and Shape:Off-WhiteMolecular weight:275.776-methoxy-N-(pyridin-2-ylmethyl)-1,3-benzothiazol-2-amine
CAS:Purity:95.0%Molecular weight:271.33999633789065-(2H-1,3-benzodioxol-5-yl)-1H-pyrazole-4-carboxylic acid
CAS:Purity:95.0%Molecular weight:232.19500732421875Lisinopril Cyclohexyl Analogue
CAS:Controlled Product<p>Impurity Lisinopril EP Impurity F<br>Applications Lisinopril Cyclohexyl Analogue (Lisinopril EP Impurity F) is a Lisinopril (L468985) impurity.<br>References Paraskevas, G., et al.: J. Pharm. Biomed. Anal., 29, 865 (2002),<br></p>Formula:C21H37N3O5Color and Shape:NeatMolecular weight:411.542-(2,6-Dichlorobenzoyl)-5-(1,3-dioxolan-2-yl)thiophene
CAS:Purity:97.0%Molecular weight:329.19000244140625Ombitasvir
CAS:Controlled Product<p>Applications Ombitasvir is a pharmaceutical drug that is used in the treatment of hepatitis C virus in patients with HCV genotype 1 infection. It inhibits an important viral phosphoprotein, NS5A, which is involved in viral replication, assembly, and secretion.<br>References Feld, J.J., et al.: New Eng. J. Med., 370, 1594 (2014); Lawitz, E., et al.: J. Hepatol., 57, 24 (2012); Afdhal, N., et al.: New England J. Med., 370, 1889 (2014)<br></p>Formula:C50H67N7O8Color and Shape:NeatMolecular weight:894.115-Hydroxy Tryptophol
CAS:Controlled Product<p>Applications A metabolite of Tryptophan (T947200).<br>References da Prada, M., et al.: Biochem. Pharmacol., 14, 1721 (1965), Curzon, G., et al.: Br. J. Pharmacol., 63, 627 (1978), Fukumori, R., et al.: J. Pharm. Pharmacol., 33, 586 (1981), Aasmoe, L., et al.: Biochem. Pharmacol., 57, 1067 (1999), Karamanakos, P., et al.: Pharmacol. Toxicol., 88, 106 (2001),<br></p>Formula:C10H11NO2Color and Shape:NeatMolecular weight:177.20Nilotinib N-Oxide
CAS:Controlled Product<p>Applications A metabolite of Nilotinib (N465300). It is a COVID19-related research product.<br></p>Formula:C28H22F3N7O2Color and Shape:NeatMolecular weight:545.52Rotigotine
CAS:Rotigotine (1-Naphthalenol, 5,6,7,8-tetrahydro-6-[propyl[2-(2-thienyl)ethyl]amino]-) is an antiparkinson agent and dopamine receptor agonist.Formula:C19H25NOSPurity:99.04% - 99.88%Color and Shape:SolidMolecular weight:315.471,2,3,4-Tetradehydro Argatroban
CAS:Controlled Product<p>Applications 1,2,3,4-Tetrahydro Argatroban is a metabolite of Argatroban (A769000); a synthetic thrombin inhibitor and antithrombotic.<br>References Abiko, Y., et al.: Thromb. Res., 24, 285 (1981); Kikumoto, R., et al.: Biochemistry, 23, 85 (1984)<br></p>Formula:C23H32N6O5SColor and Shape:NeatMolecular weight:504.606-Iodo-8-methyl-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
CAS:Purity:98%Molecular weight:329.0929870605469(E)-3-(2-Cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)acrylaldehyde
CAS:Purity:95%Molecular weight:317.3630065917969Diazoxide-d3
CAS:Controlled Product<p>Applications Diazoxide-d3 is the labeled analogue of Diazoxide (D417305), which reduces status epilepticus neuron damage in diabetes.<br>References Baba, A., et al.: J. Neurosci., 23, 7737 (2003); Bancila, V., et al.: J. Neurochem., 90, 1243 (2004); Bancila, V., et al.: J. Biol. Chem., 280, 8793 (2005)<br></p>Formula:C8H4D3ClN2O2SColor and Shape:NeatMolecular weight:233.69Dehydro Norketamine-d4 (>90%)
CAS:Controlled Product<p>Applications A labelled metabolite of Ketamine (K165300).<br>References Sullivan, H., et al.: J. Med. Chem., 16, 909 (1973), Moreton, J., et al.: J. Pharmacol. Exp. Ther., 203, 303 (1977), Lin, H., et al.: J. Food Drug Anal., 13, 107 (2005),<br></p>Formula:C12H8D4ClNOPurity:>90%Color and Shape:NeatMolecular weight:225.75N-Formyl Varenicline
CAS:Controlled Product<p>Applications A metabolite of Varenicline. Metabolite M5.<br>References Dow, J., et al.: Drug Metab. Dispos., 22, 738 (1994), Toide, K., et al.: Biochem. Pharmacol., 67, 1269 (2004), Coe, J., et al.: J. Med. Chem., 48, 3474 (2005), Doll, R., et al.: Br. J. Cancer, 92, 426 (2005),<br></p>Formula:C14H13N3OColor and Shape:NeatMolecular weight:239.27Riociguat
CAS:Controlled Product<p>Applications Riociguat is used in the treatment for pulmonary hypertension.<br>References Frey, R. et al.: J. Clin. Pharmacol., 51, 1051 (2011);<br></p>Formula:C20H19FN8O2Color and Shape:NeatMolecular weight:422.4157Nizatidine
CAS:Controlled Product<p>Applications Histamine H2-receptor antagonist related to Ranitidine (R120000). Antiulcerative.<br>References Callaghan, J.T., et al.: Clin. Pharmacol. Ther., 37, 162 (1985), Secor, J.W., et al.: Br. J. Clin. Pharmacol., 20, 710 (1985), Knadler, M.P., et al.: Drug Metab. Dispos., 14, 175 (1986), Wozniak, T.J., et al.: Anal. Profiles Drug Subs., 19, 397(1990)<br></p>Formula:C12H21N5O2S2Color and Shape:Off-White To Light YellowMolecular weight:331.462-[3,5-Dichloro-4-[(4-chlorophenyl)methyl]phenyl]-1,2,4-triazine-3,5(2H,4H)-dione
CAS:Controlled Product<p>Applications An anticoccidal triazine used for the treatment of coccidiosis in chickens. An impurity of Diclazuril (D436200).<br>References McFarland, J. et al.: J. Med. Chem., 35, 2543 (1992);<br></p>Formula:C16H10Cl3N3O2Color and Shape:NeatMolecular weight:382.63Desmethyl Fondenafil
CAS:<p>Applications Desmethyl Fondenafil is an impurity of the drug Fondenafil/Carbodenafil (F685400) a Sildenafil (S435000) related compound found in health foods.<br>References Hamilton, et al.: J. Med. Chem., 30, 91 (1987),<br></p>Formula:C23H30N6O3Color and Shape:White To Light BeigeMolecular weight:438.52Cyamemazine
CAS:<p>Applications Cyamemazine is an anxiolytic antipsychotic, which reduces ethanol withdrawal symptoms.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Robinson, et al.: J. Pharm. Pharmacol., 18, 19 (1966), Miller, L., et al.: J. Pharmacol. Exp. Ther., 246, 170 (1988), Podhorna, J., et al.: Curr. Pharm. Des., 8, 23 (2002), Hameg, A., et al.: Biochem. Pharmacol., 65, 435 (2003),<br></p>Formula:C19H21N3SColor and Shape:Green YellowMolecular weight:323.46(S)-a,a-Diphenyl-3-pyrrolidineacetamide L-Tartrate
CAS:Controlled ProductFormula:C18H20N2O·C4H6O6Color and Shape:NeatMolecular weight:430.453,5-Dimethyl-1H-pyrazole-4-sulfonyl chloride hydrochloride
CAS:Formula:C5H8Cl2N2O2SPurity:97%Color and Shape:SolidMolecular weight:231.09Des(oxopentyl) Valsartan
CAS:Controlled Product<p>Impurity Valsartan Desvaleryl Impurity<br>Applications An impurity in the synthesis of Valsartan (V095750).<br>References Carini, D., et al.: J. Med. Chem., 34, 2525 (1991), Buhlmayer, P., et al.: Bioorg. Med. Chem. Lett., 4, 29 (1994),<br></p>Formula:C19H21N5O2Color and Shape:WhiteMolecular weight:351.40Acrivastine
CAS:Controlled Product<p>Applications Acrivastine is an allergy medication that is histamine H2 antagonists.<br>References Manna, V.K., et al.: J. Int. Med. Res., 20, 106 (1992);<br></p>Formula:C22H24N2O2Color and Shape:Off White PowderMolecular weight:348.445-(4-Chloro-pyrazol-1-ylmethyl)-furan-2-carboxylic acid
CAS:Formula:C9H7ClN2O3Purity:95.0%Color and Shape:SolidMolecular weight:226.623(4-Aminophenyl)-4-methyl-4,5-dihydro-1H-pyridazin-6-one
CAS:Controlled Product<p>Applications AMDP3 (4-Aminophenyl)-4-methyl-4,5-dihydro-1H-pyridazin-6-one) acts as a cardiac troponin effecter, resulting in activation of cardiac muscle contractions. It’s an analogue to Levosimendan (L378000), positive inotropic agent with vasodilating activity.<br>References Sandell, E.-P., et al.: J. Cardiovasc. Pharmacol., 26, S57 (1995), Pagel, P.S., et al.: Cardiovasc. Drug Rev., 14, 286 (1996); Robertson, I. et al.: Biochem., 47, 7485 (2008);<br></p>Formula:C11H13N3OColor and Shape:Light Yellow To BrownMolecular weight:203.24Elvitegravir
CAS:Controlled Product<p>Applications A novel inhibitor of human immunodeficiency virus type 1 integrase.<br>References Chou, T., et al.: Eur. J. Biochem., 115, 207 (1981), Baba, M., et al.: Antimicrob. Agents Chemother., 31, 1613 (1987), Craigie, R., et al.: J. Biol. Chem., 276, 23213 (2001), Chen, X., et al.: J. Mol. Biol., 380, 504 (2008),<br></p>Formula:C23H23ClFNO5Color and Shape:NeatMolecular weight:447.88Domperidone-d6
CAS:Controlled Product<p>Applications A novel peripheral dopamine receptor antagonist that does not cross the blood-brain barrier; anti-emetic.<br>References Baudry, M., et al.: Arch. Pharmacol., 308, 231 (1979), Ennis, C., et al.: J. Pharm. Pharmacol., 31, 14 (1979), Brogden, R.N., Drugs, 24, 360 (1982),<br></p>Formula:C22H18D6ClN5O2Color and Shape:NeatMolecular weight:431.954-fluoro-N-(pyridin-2-ylmethyl)-1,3-benzothiazol-2-amine
CAS:Purity:95.0%Molecular weight:259.299987792968752-(hydroxymethyl)-4(3H)-quinazolinone hydrochloride
CAS:Formula:C9H9ClN2O2Purity:95.0%Color and Shape:SolidMolecular weight:212.63(Z)-Thiothixene-d8
CAS:Controlled ProductFormula:C23H21D8N3O2S2Color and Shape:NeatMolecular weight:451.672-Hydroxy-6-methylpyridine-3,4-dicarboxylic acid
CAS:Purity:95.0%Color and Shape:SolidMolecular weight:197.14599609375C-[5-(4-Thiophen-2-yl-phenyl)-[1,3,4]oxadiazol-2-yl]-methylamine; hydrochloride
Purity:95.0%Molecular weight:293.76998901367192-((2R,3R)-4-(Anthracen-9-yl)-3-(tert-butyl)-2,3-dihydrobenzo[d][1,3]oxaphosphol-2-yl)pyridine
CAS:Purity:97%Molecular weight:447.518005371093751-[3-(Dimethylamino)propyl]-3-ethylurea
CAS:Controlled Product<p>Applications 1-[3-(Dimethylamino)propyl]-3-ethylurea is a reagent used in the preparation of water soluble, multifunctional antibody-porphyrin gold nanoparticles.<br>References Penon, O. et al.: J. Colloid. Inter. Sci., 496, 100 (2017);<br></p>Formula:C8H19N3OColor and Shape:NeatMolecular weight:173.26Cathine Hydrochloride
CAS:Controlled ProductFormula:C9H13NO·ClHColor and Shape:Off-WhiteMolecular weight:187.67Oxyphenbutazone
CAS:<p>Applications Anti-inflammatory.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Yoshida, F., et al.: J. Med. Chem., 43, 2575 (2000), Chen, M., ET AL.: Pharm. Res., 18, 1645 (2001), Davis, A., et al.: Curr. Opin. Chem. Biol., 8, 378 (2004), Wang, J., ET AL.: Anal. Chim. Acta, 601, 156 (2007),<br></p>Formula:C19H20N2O3Color and Shape:NeatMolecular weight:324.372-[5-amino-3-(2-thienyl)-1H-pyrazol-1-yl]-5-ethyl-6-methylpyrimidin-4(3H)-one
CAS:Purity:95.0%Molecular weight:301.3699951171875Cilostazol-d11
CAS:Controlled Product<p>Applications A potent phosphodiesterase III A (PDE3A) inhibitor (IC50=0.2uM) and inhibitor of adenosine uptake. Has antimitogeni, antithrombotic, vasodilatory and cardiotonic properties in vivo. Also affects lipid levels in vivo.<br>References Suri, A., et al.: J. Clin. Pharmacol., 38, 144 (1998), Park, S.-W., et al.: Am. J. Cardiol., 84, 511 (1999), Tsuchikane, E., et al.: Circulation, 100, 21 (1999),<br></p>Formula:C20H16D11N5O2Color and Shape:NeatMolecular weight:380.52



